TOW
30.3.2021 04:02:12 CEST | Business Wire | Press release
TOW Co., Ltd.:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210329005028/en/
[https://tow.co.jp/certification/
]
Follow this link for a documentary that demonstrates the value of the certification system through the stories of foreign chefs attempting the test for Gold Certification, the system’s highest outlined standard.
The Ministry of Agriculture, Forestry and Fisheries has established Guidelines for the Certification of Cooking Skills for Japanese Cuisine in Foreign Countries as of April 2016.
This system lays out specific standards that private bodies may use to recognize foreign chefs who have acquired given levels of knowledge and cooking skills necessary for the preparation of Japanese cuisine, to help ensure that the appeals of Japanese food and dietary culture, as well as of Japanese agricultural and marine products, are appropriately and effectively communicated throughout the world.*
And through it, the private sector is able to position itself as a driving force in promoting efforts to certify Japanese cuisine cooking skills, increasing the number of certified individuals, and fostering further growth in foreign chefs who have acquired the appropriate knowledge and skills for preparation of Japanese cuisine, all with the ultimate goal of further strengthening the global reputation of Japanese food and dietary culture and expanding consumption of Japanese agricultural and marine products.
To that end, TOW Co., Ltd. is actively engaged as the Application/Management Body of the Certification System. As of March 2021, it has approbated 11 certifying bodies, which have in turn recognized 14 individual chefs as meeting Gold Certification standards, 187 meeting Silver, and 389 meeting Bronze.
Though the COVID-19 pandemic has dealt a significant blow to the food service industry worldwide, TOW Co., Ltd. remains committed to carrying out its missions, and to encouraging all foreign chefs aspiring to obtain the knowledge and skills to properly prepare Japanese cuisine. It is our hope that the creation and sharing of this video introducing the System for Certification of Cooking Skills for Japanese Cuisine will help fulfill those goals.
*Certification standards
Gold
Those who have approximately two years practical experience in a Japanese restaurant located in Japan whose head chef is Japanese and are deemed to have acquired knowledge and skills specified.
Knowledge and Skills to be Acquired
-
Knowledge regarding Japanese dietary culture
Knowledge regarding Japanese dietary culture, Japanese foods, eating style, Japanese sake and tea. -
Knowledge regarding hygiene management
Types and prevention of food poisoning, clothing, handling of food ingredients, cleaning and sterilization of cooking utensils and equipment, food ingredients and foods that require heating treatment. -
Techniques
How to use Japanese cooking utensils and equipment, how to select food ingredients, how to cut and peel food ingredients, procedures and hours required for cooking, heat level/mechanism of application of heat, how to make dashi (Japanese soup stock), blending ratios of seasonings, presentation, preservation method, preparation of menu. -
Omotenashi
Words, greeting, consideration, manners, how to place meals.
Silver
Those who took lessons and acquired knowledge and skills regarding Japanese cuisine specified approximately one year at any cooking schools located in and out of their own country and then graduated from said school.
OR
Those who have approximately one year practical experience in a Japanese restaurant located in Japan whose head chef is Japanese and are deemed to have acquired knowledge and skills specified.
Knowledge and Skills to be Acquired
-
Knowledge regarding Japanese dietary culture
Knowledge regarding Japanese dietary culture, Japanese foods, eating style -
Knowledge regarding hygiene management
Types and prevention of food poisoning, clothing, handling of food ingredients, cleaning and sterilization of cooking utensils and equipment, food ingredients and foods that require heating treatment. -
Techniques
How to use Japanese cooking utensils and equipment, how to select food ingredients, how to cut and peel food ingredients, blending ratios of seasonings, procedures and hours required for cooking, heat level/mechanism of application of heat, how to make dashi (Japanese soup stock), presentation, preservation method. -
Omotenashi
Manners, how to place meals
Bronze
Those who received training regarding knowledge and skills specified in short-term sessions etc. organized by any Japanese cooking school and/or private bodies located in and out of their own countries and then passed the examination conducted by the Certification Body.
Knowledge and Skills to be Acquired
-
Knowledge regarding Japanese dietary culture
Knowledge regarding Japanese dietary culture -
Knowledge regarding hygiene management
Prevention of food poisoning, clothing, handling of food ingredients, cleaning and sterilization of cooking utensils and equipment, food ingredients and foods that require heating treatment. -
Techniques
How to use Japanese cooking utensils and equipment, how to select food ingredients, how to cut and peel food ingredients, blending ratios of seasonings, procedures and hours required for cooking, presentation, preservation method. -
Omotenashi
Manners
View source version on businesswire.com: https://www.businesswire.com/news/home/20210329005028/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
GE HealthCare Announces First Patient Dosed in Phase 2/3 LUMINA Trial for Manganese-Based MRI Contrast Agent Under FDA Fast Track Designation, Further Advancing Its Innovation Pipeline of Novel Imaging Agents23.4.2026 13:29:00 CEST | Press release
Mangaciclanol, if approved, could transform contrast-enhanced MR imaging by offering an alternative to - or even replacing - gadolinium-based MRI agentsA manganese-based MRI contrast agent could address concerns with gadolinium-based contrast agents around retention in the body, security of supply, and the environment, with mangaciclanol’s clinical development under FDA Fast Track designationThe program demonstrates GE HealthCare’s commitment to advancing novel imaging agents to address unmet patient needs GE HealthCare (Nasdaq: GEHC) today announced the first patient has been dosed in the international, multi-center Phase 2/3 LUMINA clinical trial of its manganese-based magnetic resonance imaging (MRI) contrast agent, mangaciclanol, at Mayo Clinic in Rochester, Minnesota. Mangaciclanol, if approved, could offer an alternative to – or even replace – gadolinium-based MRI contrast agents, the current standard of care. The investigational agent has been granted Fast Track designation by t
Croma Pharma Launches AI-Driven Tech Venture to Revolutionize Aesthetic Medicine via Clinicore Platform23.4.2026 13:13:00 CEST | Press release
New structure to drive AI-powered innovation and international expansion Croma Pharma has launched a strategic joint venture to accelerate the development of Clinicore, its premium digital solution for aesthetic practices. This dedicated entity will focus on scaling the next generation of the platform while ensuring full continuity for existing users. Clinicore: Elevating Practice Excellence through AI Clinicore is a specialized SaaS (Software as a Service) solution designed to optimize the daily operations of aesthetic clinics. By automating patient management, scheduling, and administrative workflows, it enables healthcare professionals to focus entirely on patient care. A core element of the new strategy is a strong focus on Artificial Intelligence. Clinicore is evolving into a smart assistant, utilizing AI-driven features for automated treatment documentation, intelligent onboarding tools, and advanced process automation. This ensures that clinics can operate at maximum efficiency
NIQ Launches Commerce Lab to Build the Data and Measurement Layer for AI-Driven Commerce23.4.2026 13:00:00 CEST | Press release
NielsenIQ (NYSE: NIQ) today announced the launch of NIQ Commerce Lab, where the company is building the technology infrastructure for AI-driven commerce. The Lab will develop the data platforms, APIs, and measurement systems that power how products are discovered, evaluated, and purchased in AI-mediated environments. This includes what the industry often refers to as agentic commerce, but extends across quick commerce, social commerce, and other emerging channels—where AI is becoming the common layer shaping how consumers navigate choices and how decisions are made in real time. AI systems are rapidly moving from supporting decisions to making them—playing an increasingly central role in how commerce operates. Their effectiveness depends on the intelligence behind them. AI is Becoming the Operating Layer of Global Commerce NIQ ensures that the intelligence behind these systems is accurate, complete, and grounded in real-world behavior—reflecting how consumers actually buy, what product
Chiesi Reports Strong FY2025 Financial and Sustainability Results and Announces Leadership Transition Highlights23.4.2026 12:10:00 CEST | Press release
Strong FY2025 financial and sustainability results; leadership transition will support continuity and long-term growth Revenue up 8.2% to €3.6bn with double-digit growth in Rare Diseases and U.S. market Air sales at €1.886bn, growing 3.9% vs. 2024 - Care sales at €904m growing 13.3% vs. 2024 - Rare sales at €906m, growing 22.3% vs. 2024 Giuseppe Accogli leaving to pursue another opportunity, Group CFO Jean-Marc Bellemin named Interim CEO while new CEO search is underway Record €885m Research & Development (R&D) investment underscores continued commitment to innovation across respiratory, rare disease and specialty care Sustainability leadership further strengthened through B Corp recertification and progress on Carbon Minimal Inhaler (CMI) innovation Chiesi Group (“Chiesi”), an international research‑focused biopharmaceutical company and certified B Corp, today announced its financial results for the year ended 31 December 2025. Chiesi reported €3.625 billion in consolidated revenues,
REPLY S.p.A.: Shareholders’ Meeting Approves the 2025 Financial Statements23.4.2026 12:05:00 CEST | Press release
Consolidated turnover of €2,483.6 million (€2,300.5 million in 2024);Group net profits of €250.9 million (€211.1 million in 2024).Approval of the proposal to distribute a dividend of €1.35 per share.Approval of the plan for the purchase and/or disposal of treasury shares. The General Shareholders’ meeting of Reply S.p.A. [EXM, STAR: REY] held today approved the Financial Statements for the financial year 2025, confirming the distribution of a gross dividend of €1.35 per share. The dividend will be paid on 20 May 2026, with dividend date set on 18 May 2026 (record date on 19 May 2026). Approval of the 2025 financial statements The Reply Group closed the 2025 financial year with a consolidated turnover of €2,483.6 million, recording a 8.0% increase compared to €2,300.5 million in 2024. Consolidated EBITDA was €467.6 million, up 13.9% compared to €410.6 million recorded for the year 2024. EBIT, from January to December, was €397.1 million, up 18.5% compared to €330.4 million recorded for
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
